Bangladesh, Nov. 11 -- Square Pharmaceuticals saw moderate profit growth in the first quarter (July-September) of FY27, reflecting improved revenue generation, stronger gross profitability and favourable operating performance.

The company's consolidated profit advanced 5.02 per cent year-on-year to Tk 7.77 billion in Q1 FY27. Its revenue increased 3.95 per cent to Tk 22.44 billion during the quarter, compared with the corresponding period of the previous year.

As the cost of goods sold declined 0.86 per cent, the company was able to generate an 8.37 per cent year-on-year growth in gross profit during the quarter.

Lower finance costs provided additional support to operating profitability. Furthermore, other operating income helped stre...